Cliff Asness's NMRA Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 55,995 shares of Neumora Therapeutics, Inc. (NMRA) worth $109,189, representing 0.00% of the portfolio. First purchased in 2025-Q1, this short-term holding has been held for 5 quarters.
Based on 13F filings, Cliff Asness has maintained this position in NMRA for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2025, adding 313,469 shares. Largest reduction occurred in Q3 2025, reducing 568,415 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Neumora Therapeutics (NMRA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Neumora Therapeutics (NMRA) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -38,175 | Reduce 40.54% | 55,995 | $1.95 |
| Q4 2025 | -113,487 | Reduce 54.65% | 94,170 | $1.79 |
| Q3 2025 | -568,415 | Reduce 73.24% | 207,657 | $1.82 |
| Q2 2025 | +313,469 | Add 67.76% | 776,072 | $0.73 |
| Q1 2025 | +462,603 | New Buy | 462,603 | $1.00 |
Cliff Asness's Neumora Therapeutics Investment FAQs
Cliff Asness first purchased Neumora Therapeutics, Inc. (NMRA) in Q1 2025, acquiring 462,603 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Neumora Therapeutics, Inc. (NMRA) for 5 quarters since Q1 2025.
Cliff Asness's largest addition to Neumora Therapeutics, Inc. (NMRA) was in Q1 2025, adding 462,603 shares worth $462,603.
According to the latest 13F filing for Q1 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 55,995 shares of Neumora Therapeutics, Inc. (NMRA), valued at approximately $109,189.
As of the Q1 2026 filing, Neumora Therapeutics, Inc. (NMRA) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Neumora Therapeutics, Inc. (NMRA) was 776,072 shares, as reported at the end of Q2 2025.